View printer-friendly version << Back
MEDNAX Announces Acquisition of Anesthesiology Practice in Georgia

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Mar. 16, 2016-- MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Anesthesia Associates of Savannah, PA, and Lighthouse Anesthesia, LLC, collectively known as Lighthouse Anesthesia, a private physician group practice based in Savannah, Ga.

Lighthouse Anesthesia has been providing anesthesia care in the Southeast Georgia market for more than 60 years. The practice employs 102 full-time clinicians (28 anesthesiologists and 74 anesthetists) that provide services to St. Joseph’s/Candler, a 714-bed health care system in Savannah, Effingham Hospital and Care Center in Springfield, Ga., and 11 ambulatory surgery centers located throughout Georgia and North Carolina. Lighthouse Anesthesia’s inpatient and outpatient anesthesia services include general surgery, orthopedic, neurosurgery, cardiac, vascular and pediatric.

“After an extensive due diligence process that involved input from hospital administrators and affiliated clinicians, it was clear MEDNAX was the right choice,” said Richard Dodd, M.D., who will serve as medical director for the practice. “MEDNAX’s proven infrastructure as well as its research, education and quality initiatives, will support improved clinical outcomes and help us meet and exceed benchmarks in an increasingly complex and demanding healthcare environment.”

This acquisition adds to the services MEDNAX provides in Georgia across multiple specialties which include anesthesia, obstetric, maternal-fetal, neonatal and hearing screen services.

This was a cash transaction, and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.


MEDNAX, Inc. is a national medical group comprised of the nation's leading providers of physician services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives, clinical research and telemedicine to enhance patient outcomes and provide high-quality, cost-effective care. The Company was founded in 1979, and today, through its affiliated professional corporations, MEDNAX provides services through a network of more than 3,300 physicians in all 50 states and Puerto Rico. In addition to its national physician network, MEDNAX provides services to healthcare facilities and physicians in over 40 states through two complementary businesses, consisting of a revenue cycle management company and a consulting services company. Additional information is available at

Certain statements and information in this press release may be deemed to contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may include, but are not limited to, statements relating to our objectives, plans and strategies, and all statements, other than statements of historical facts, that address activities, events or developments that we intend, expect, project, believe or anticipate will or may occur in the future. These statements are often characterized by terminology such as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”, “will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and similar expressions, and are based on assumptions and assessments made by MEDNAX’s management in light of their experience and their perception of historical trends, current conditions, expected future developments and other factors they believe to be appropriate. Any forward-looking statements in this press release are made as of the date hereof, and MEDNAX undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in MEDNAX’s most recent Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q, including the sections entitled “Risk Factors”, as well MEDNAX’s current reports on Form 8-K, filed with the Securities and Exchange Commission.

Source: MEDNAX, Inc.

Charles Lynch, 954-384-0175, Ext. 5692
Vice President, Strategy and Investor Relations